Efficacy and Safety of 0.01% and 0.02% Atropine for the Treatment of Pediatric Myopia Progression Over 3 Years: A Randomized Clinical Trial.
Sign Up to like & getrecommendations! Published in 2023 at "JAMA ophthalmology"
DOI: 10.1001/jamaophthalmol.2023.2097
Abstract: Importance The global prevalence of myopia is predicted to approach 50% by 2050, increasing the risk of visual impairment later in life. No pharmacologic therapy is approved for treating childhood myopia progression. Objective To assess… read more here.
Keywords: dose atropine; myopia progression; progression; trial ... See more keywords
Analysis of treatment response about low-dose (0.01%) atropine eye-drops in myopic children.
Sign Up to like & getrecommendations! Published in 2021 at "European journal of ophthalmology"
DOI: 10.1177/11206721211038817
Abstract: INTRODUCTION Myopia usually commences during primary school and progresses until the mean age of 16 years. Topical low-dose (0.01%) atropine eye-drop appears to be safe and efficacious for myopia control in children. However, in some cases,… read more here.
Keywords: low dose; treatment; atropine; atropine eye ... See more keywords
Classification-Based Approaches to Myopia Control in a Taiwanese Cohort
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.879210
Abstract: Purpose Myopia is a disorder of growing prevalence in school-aged children worldwide, especially in Asia. Although low-dose atropine is recognized as an effective treatment to slow myopia progression, different studies have reported varying efficacies of… read more here.
Keywords: classification based; dose atropine; progression; risk ... See more keywords
Commentary: Low-dose atropine: How clear is the view?
Sign Up to like & getrecommendations! Published in 2022 at "Indian Journal of Ophthalmology"
DOI: 10.4103/ijo.ijo_595_22
Abstract: Myopia is an under acknowledged epidemic which has already affected nearly 30% of the world population in 2020. According to current projections, this number is expected to rise to 50% by 2050, of which 10%… read more here.
Keywords: clear view; dose atropine; myopia; low dose ... See more keywords